Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
RADL3.SA
HoldRaia Drogasil S.A. · Healthcare · Brazil · $6.7B · Avg Vol: $37M/d
64
StockRankGet insider-trade alerts
Q
67
V
45
M
47
P/E (TTM)
22.7x
ROE
20.0%
D/E
1.2x
Dividend %
1.3%
COMPANY DESCRIPTION
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A.
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29.1B | 34.0B | 38.9B | 44.3B | 15.0% | 47.1B | 45.5B | 52.0B | 8.4% |
| EPS (BRL) | 0.59 | 0.63 | 0.71 | 0.79 | 9.9% | 0.86 | 0.89 | 1.18 | 22.2% |
| Shares | 1.7B | 1.7B | 1.7B | 1.8B | +2.0% | 1.7B | — | — | — |
| Debt | 6.1B | 7.1B | 7.7B | 8.8B | 13.4% | 8.7B | — | — | — |
| Equity | 5.3B | 6.0B | 6.4B | 7.3B | 11.1% | — | — | — | — |
| Op CF | 839.3M | 962.5M | 1.9B | 1.5B | 21.6% | 3.1B | — | — | — |
| Inv CF | -1.2B | -1.3B | -1.4B | -1.4B | — | — | — | — | — |
| Fin CF | 467.7M | 323.3M | -384.0M | -122.1M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+3.6%
SMA 50SMA 200
Close
$3.72
RSI (14)
49.8
52W High
$5.21
From 52W High
0.7%
SCORE BREAKDOWN
Quality
67
ROIC
16.8%87.9
ROE
20.0%88.2
GP/Assets
56.0%89.9
Op. Margin
7.6%59.4
FCF/Assets
0.4%47.3
Piotroski
497.6
Int. Cover
2.4x45.6
D/E Ratio
1.18x11.8
Current Ratio
1.41x24.2
Value
45
P/E (TTM)
22.7x53.2
EV/EBITDA
10.8x64.8
P/FCF
321.7x4.9
P/B
4.6x30.9
P/S
0.7x88.6
Div Yield
1.3%31.8
Momentum
47
52W High %
71%51.3
RS 6M
-15%48.9
SMA 50/200
0.85x25.6
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+37%48.0
Q Growth
14%51.1
FUNDAMENTALS
Market Cap
$6.7B
P/E (Forward)
16.5x
Gross Margin
30.3%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of RADL3.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| RADL3.SA | Raia Drogasil S.A.(you) | $6.7B | 64 | Hold |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $490M | 75 | Buy |
| DMVF3.SA | d1000 Varejo Farma Participações S.A. | $62M | 95 | Strong Buy |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $15.3B | 82 | Strong Buy |
| SAUD3.SA | Bradsaúde S.A. | $7.9B | 97 | Strong Buy |
| HYPE3.SA | Hypera S.A. | $3.0B | 97 | Strong Buy |
| DASA3.SA | Diagnósticos da América S.A. | $636M | 59 | Hold |
| FLRY3.SA | Fleury S.A. | $2.0B | 99 | Strong Buy |
| BLAU3.SA | Blau Farmacêutica S.A. | $415M | 88 | Strong Buy |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $353M | 94 | Strong Buy |
Peer medians: ROE 10.5% · P/E 12.4x · Gross margin 31.0%